Literature DB >> 466004

Acute phase reactant proteins in the clinical management of carcinoma of the bladder.

J R Bastable, B Richards, S Haworth, E H Cooper.   

Abstract

The levels of a number of acute phase reactant proteins have been measured in 250 patients with carcinoma of the bladder in all stages. Three of them, acid glycoprotein, antichymotrypsin, and C-reactive protein, frequently gave abnormal results in advanced disease. The levels of these 3 proteins in patients who were clinically tumour-free were not distinguishable from those from an age-matched control group. The levels in patients with T1 and T2 bladder tumours were sometimes elevated. In advanced disease, figures were commonly above the normal range.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 466004     DOI: 10.1111/j.1464-410x.1979.tb04710.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  5 in total

1.  The diagnostic and prognostic value of urinary polyamine measurement in bladder cancer.

Authors:  P Pastorini; G Milano; J Toubol; G Raymond; P Cambon; C M Lalanne
Journal:  Urol Res       Date:  1981

2.  Immunological studies of patients with tumours of the prostate and bladder (a retrospective analysis).

Authors:  I Romics; J Fehér; J Horváth
Journal:  Int Urol Nephrol       Date:  1983       Impact factor: 2.370

3.  The investigation of cellular and humoral immune reactivity in patients with tumours of the bladder.

Authors:  I Romics; J Fehér; J Horváth; L Kisbenedek; F Balogh
Journal:  Int Urol Nephrol       Date:  1982       Impact factor: 2.370

4.  Serum proteins as tumour markers for breast cancer.

Authors:  P Mattison; D H Cove; L Walsh; A Howell; B McConkey; J M Morrison
Journal:  Br J Cancer       Date:  1981-04       Impact factor: 7.640

5.  Plasma protein profiles and prognosis in gastric cancer.

Authors:  S A Rashid; J O'Quigley; A T Axon; E H Cooper
Journal:  Br J Cancer       Date:  1982-03       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.